Contineum Therapeutics, Inc. · NASDAQ:CTNM

Lorrain Daniel S. sold 4,170 Contineum Therapeutics, Inc. shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 6, 2026

On Apr 6, 2026, Lorrain Daniel S. (Chief Scientific Officer) sold 4,170 Contineum Therapeutics, Inc. shares at US$13.43 for US$56,003 under a trading plan, leaving 147,712 shares. Filed Apr 6, 2026 (Form 4).

Sold
4,170 shares
Price
US$13.43
Value
US$56,003
Holding after
147,712 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Class A Common StockSale4,170US$13.43147,712Direct

Source

View original at SEC

Related